Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Singleton who wrote (4998)	7/26/1998 1:01:00 AM
From: Peter Singleton	of 6136

Another quality post from the IMNR thread on Yahoo ... I've cited the link and pulled a couple of key quotes post.messages.yahoo.com@m2.yahoo.com <<I ask because I've been under the impression that they already have enough data to pursue a fast track filing if they wanted to be aggresive, and, now, perhaps they want to be. ... I've long been intrigued by their monotherapy trials being conducted in Thailand, feeling that these are the "cleanest" test of Remune. Without revealing any names, I spoke with someone at IMNR (not IR or Gibson group) after Geneva who told me that the Thailand data will be published in an HIV journal in about a month (weight gain, increased CD4 count, increased CD4 ratio, and decreased viral load) and also intimated that fast track approval is being pursued in Asia. >>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next